News

Zai Lab Limited (NASDAQ: ZLAB) added 5.65 per cent on Tuesday to close at $19.65, lifted by news that the FDA has extended a second Fast Track Designation to zocilurtatug pelitecan — known within the oncology community as zoci — for the treatment of …

Exagen Inc. (NASDAQ: XGN) surged 25.42 per cent to $3.70 on Tuesday after the medical diagnostics company reported a first quarter that exceeded expectations on the metrics that matter most for a diagnosticsBusinessat this stage of its commercial development: volume, pricing, and the trajectory …

Actuate Therapeutics (NASDAQ: ACTU) suffered a sharpReversalon Tuesday, declining 11.82 per cent to $2.91, in what may rank as one of the more counterintuitive market reactions of the day. The company had just announced that the US Food and Drug Administration had cleared its …